News · 26 weeks39-37%
2025-10-262026-04-19
Mix2090d
- Other5(25%)
- SEC Filings5(25%)
- Insider5(25%)
- Earnings3(15%)
- Leadership2(10%)
Latest news
25 items- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- PRAcadia Healthcare Appoints David Duckworth as Interim Chief Financial OfficerReaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int
- INSIDERSEC Form 4 filed by Farley Brian4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERSEC Form 4 filed by Young Todd S.4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- PRAcadia Healthcare Announces Date for First Quarter 2026 Earnings ReleaseAcadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of the market. Acadia will also conduct a conference call with institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2025, Acadia operated a network of 277 behavioral healthcare fa
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
- SECSEC Form DEFA14A filed by Acadia Healthcare Company Inc.DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- SECSEC Form DEF 14A filed by Acadia Healthcare Company Inc.DEF 14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- INSIDERSEC Form 4 filed by Cancelmi Daniel J4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cancelmi Daniel J3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- PRAcadia Healthcare Appoints Daniel Cancelmi to Board of DirectorsWade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in
- PRAnxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar ExpansionGAD Therapies Market Set to Explode to $4.26B by 2033 as Demand Rockets for Innovative Anxiety Solutions NEW YORK, March 5, 2026 /CNW/ -- Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry and stress. Traditional medications like anti-anxiety drugs and antidepressants still play a big role, but therapy options such as cognitive-behavioral therapy and mindfulness techniques are also helping people manage symptoms without relying only on medication. Digital mental health tools and telehealth visits are making treatment easier to access, especially f
- INSIDEREVP, GC and Secretary Farley Brian covered exercise/tax liability with 1,915 shares, decreasing direct ownership by 3% to 69,165 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- PRAcadia Healthcare Announces Fourth Quarter and 2025 ResultsCompany Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company's previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3% Net loss attributable
- PRAcadia Healthcare to Participate in March Investor ConferencesAcadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company's presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Company will participate in the Leerink Partners 2026 Global Healthcare Conference, being held March 9-12, 2026, in Miami, Florida. The Company's presentation will begin at 3:40 p.m. Eastern Time/2:40 p.m. Central Time. On Tuesday, Marc
- SECSEC Form SCHEDULE 13G filed by Acadia Healthcare Company Inc.SCHEDULE 13G - Acadia Healthcare Company, Inc. (0001520697) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
- PRAcadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings ReleaseAcadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States (the "U.S."). As of September 30, 2025, Acadia operated a network of
- SECSEC Form 8-K filed by Acadia Healthcare Company Inc.8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- ANALYSTAcadia Healthcare downgraded by Jefferies with a new price targetJefferies downgraded Acadia Healthcare from Buy to Hold and set a new price target of $15.00
- INSIDERSEC Form 4 filed by Chief Executive Officer Osteen Debra K4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERNew insider Osteen Debra K claimed ownership of 3,765 shares (SEC Form 3)3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)